The Senescent Heart—“Age Doth Wither Its Infinite Variety” DOI Open Access

Anupama Vijayakumar,

Mingyi Wang, Shivakumar Kailasam

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(7), С. 3581 - 3581

Опубликована: Март 22, 2024

Cardiovascular diseases are a leading cause of morbidity and mortality world-wide. While many factors like smoking, hypertension, diabetes, dyslipidaemia, sedentary lifestyle, genetic can predispose to cardiovascular diseases, the natural process aging is by itself major determinant risk. Cardiac marked conglomerate cellular molecular changes, exacerbated age-driven decline in cardiac regeneration capacity. Although phenotypes well characterised, underlying mechanisms far less explored. Recent advances unequivocally link dysregulation critical signalling pathways fibroblasts, which compromises role these cells maintaining structural functional integrity myocardium. Clearly, identification fibroblast-specific that regulate fibroblast function senescent myocardium immense importance. In this regard, recent studies show Discoidin domain receptor 2 (DDR2), collagen-activated tyrosine kinase predominantly located has an obligate fibrosis. Incisive on basis dysregulated heart would pave way for effective strategies mitigate rapidly growing elderly population.

Язык: Английский

Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis DOI Creative Commons
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto

и другие.

Biomedicines, Год журнала: 2024, Номер 12(6), С. 1331 - 1331

Опубликована: Июнь 14, 2024

In systemic sclerosis (SSc, or scleroderma), defective angiogenesis, clinically manifesting with abnormal capillary architecture and severe reduction, represents a hallmark of early-stage disease, usually preceding the onset tissue fibrosis, is caused by several cellular molecular mechanisms affecting microvascular endothelial cells different outcomes. Indeed, once damaged, can be dysfunctionally activated, thus becoming unable to undergo angiogenesis promoting perivascular inflammation. They also apoptosis, transdifferentiate into profibrotic myofibroblasts, acquire senescence-associated secretory phenotype characterized release exosomes proinflammatory mediators. this narrative review, we aimed give comprehensive overview recent studies dealing underlying SSc related cell dysfunctions, mainly endothelial-to-mesenchymal transition process. We discussed potential novel vascular treatment strategies able restore angiogenic process reduce in complex disease.

Язык: Английский

Процитировано

4

Atherosclerotic cardiovascular disease in aging and the role of advanced cardiovascular imaging DOI Creative Commons
Jie Jun Wong, Rilong Hong,

Louis Teo

и другие.

Deleted Journal, Год журнала: 2024, Номер 1(1)

Опубликована: Авг. 2, 2024

Abstract Aging and inflammation are key drivers in the pathogenesis of cardiovascular disease. is characterized by chronic, systemic, dysregulated dysfunctional immune responses ― termed inflammaging that give rise to cumulative damage. These noxious processes promote epithelial dysfunction, infiltration, foam cell deposition, calcification, which result atherosclerotic plaque formation. With aging, vascular smooth muscle senescence further contribute atherogenesis acquisition senescence-associated secretory phenotype, consequently secreting pro-inflammatory pro-fibrotic factors exert autocrine paracrine effects perpetuate a vicious cycle tissue aging eventual failure. Recent evidence has affirmed use anti-inflammatory therapy reduce risk; however, possibility off-target adverse may limit application. Moreover, systemic inflammatory markers not sufficiently precise localizing active inflammation, conventional imaging methods can only detect structural changes late-stage Targeted molecular offers imaging-guided precision theragnostic early upstream preventive approaches delineating cellular biological mechanisms underpinning holds potential revolutionize personalized treatment Here, we examine recent developments relation underlying aging-related We highlight challenges facing translation into clinical practice propose future directions these novel diagnostic modalities.

Язык: Английский

Процитировано

4

The interplay of senescence and MMPs in myocardial infarction: implications for cardiac aging and therapeutics DOI

Ashok Kumar Balaraman,

Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu

и другие.

Biogerontology, Год журнала: 2025, Номер 26(1)

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

0

Cellular senescence and PAPP-A DOI
Cheryl A. Conover

Growth Hormone & IGF Research, Год журнала: 2025, Номер 80, С. 101637 - 101637

Опубликована: Янв. 23, 2025

Язык: Английский

Процитировано

0

Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment DOI Creative Commons
Yulia Aleksandrova, Маргарита Е. Неганова

Antioxidants, Год журнала: 2025, Номер 14(2), С. 199 - 199

Опубликована: Фев. 10, 2025

Aging is a general biological process inherent in all living organisms. It characterized by progressive cellular dysfunction. For many years, aging has been widely recognized as highly effective mechanism for suppressing the progression of malignant neoplasms. However, recent increasing evidence suggests “double-edged” role cancer development. According to these data, not only tumor suppressor that leads cell cycle arrest neoplastic cells, but also promoter ensures chronic proinflammatory and immunosuppressive microenvironment. In this regard, our review, we discuss data on destructive senescent cells pathogenesis cancer. We identify first time correlations between modulation senescence-associated secretory phenotype antitumor effects naturally occurring molecules.

Язык: Английский

Процитировано

0

Cellular senescence and senotherapeutics in cardiovascular diseases DOI

Arttatrana Pal

Advances in pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

KAT7 contributes to ponatinib-induced hypertension by promoting endothelial senescence and inflammatory responses through activating NF-κB signaling pathway DOI Creative Commons
Xinyu Xu, Mei Zhang,

Qi Qin

и другие.

Journal of Hypertension, Год журнала: 2025, Номер unknown

Опубликована: Март 10, 2025

Background and purpose: Ponatinib, a tyrosine kinase inhibitor (TKI) leads to hypertension; however, the mechanisms remain elusive. We aimed investigate whether lysine acetyltransferase 7 (KAT7), key regulator of cellular senescence that is closely associated with cardiovascular diseases, involves in ponatinib-induced hypertension. Methods results: After administering ponatinib Sprague–Dawley (SD) rats for 8 days, we measured blood pressure, vasodilation, endothelial function using tail-cuff plethysmography, isometric myography, Total NO Assay kit, respectively. The results indicated increased impaired endothelium-dependent relaxation (EDR), caused injury cells SD rats. Furthermore, PCR Western blot experiments demonstrated an upregulation KAT7 expression rat mesenteric artery (MAECs) following treatment. To further study role hypertension, divided into four groups: control, ponatinib, WM-3835 (a inhibitor), plus WM-3835. Notably, administration significantly improved hypertension EDR dysfunction Mechanistically, over-expression (OE-KAT7) MAECs led inflammation, phenomena were also observed arteries ponatinib-treated exposed ponatinib. However, mitigated these detrimental effects both vivo vitro experiments. Additionally, OE-KAT7 treatment induced H3K14 acetylation (H3K14ac), elevating recruitment H3K14ac p21 promoter. Moreover, BAY 11-7085, nuclear factor (NF)-κB inhibitor, potently alleviated accumulation IL-6 IL-8, as well cell by overexpression. Conclusion: Our data indicate elevation inflammatory responses through NF-κB signaling pathway, subsequently vasotoxicity

Язык: Английский

Процитировано

0

Prevention of cardiovascular disease for healthy aging and longevity: A new scoring system and related “mechanisms-hallmarks-biomarkers” DOI
Chunsong Hu

Ageing Research Reviews, Год журнала: 2025, Номер unknown, С. 102727 - 102727

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Senescent cells as a target for anti-aging interventions: From senolytics to immune therapies DOI
Tao Fu, Zhongjun Zhou

Journal of Translational Internal Medicine, Год журнала: 2025, Номер 13(1), С. 33 - 47

Опубликована: Фев. 1, 2025

Aging and age-related diseases are major drivers of multimorbidity mortality worldwide. Cellular senescence is a hallmark aging. The accumulation senescent cells causally associated with pathogenesis various age-associated disorders. Due to their promise for alleviating disorders extending healthspan, therapeutic strategies targeting (senotherapies) as means combat aging have received much attention over the past decade. Among conventionally used approaches, one usage small-molecule compounds specifically exhibit cytotoxicity toward or inhibit deleterious effects senescence-associated secretory phenotype (SASP). Alternatively, there immunotherapies directed at surface antigens upregulated in (seno-antigens), including chimeric antigen receptor (CAR) therapies senolytic vaccines. This review gives an update current status discovery development therapies, translational progress from preclinical clinical trials. We highlight challenges faced by senotherapeutic context heterogeneity, aim offering novel perspectives future anti-aging interventions aimed enhancing healthy longevity.

Язык: Английский

Процитировано

0

Risk of senescence, polypharmacy, and their outcomes in elderly cardiovascular disease patients DOI
Tamer Cebe, Fatih Kızılyel

Advances in pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0